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Scope of mental health problems in 
adolescence
It is estimated that about 20% of children and adolescents have a 
mental health disorder and approximately half of all mental illness 
and substance-related problems start at the age of 14 years.[1] The 
risk of mental health problems is further exacerbated in vulnerable 
environments with poor social support and socioeconomic 
inequalities, such as developing countries.[2] In a study of mental 
health among 15 - 19-year-old youth in five cities globally, female 
adolescents from Johannesburg reported the highest levels of 
depression and post-traumatic stress symptoms (44.6% and 67.0%, 
respectively).[2] Suicide remains the second leading cause of death 
among young people worldwide.[3] Common psychiatric disorders 
in adolescents, including anxiety-, mood-, trauma- and stressor-
related disorders, are all associated with increased suicide risk.[3]
Importance of assessing and treating 
mental health problems in adolescence
The majority of adolescents with mental illness remain undiagnosed 
and untreated, and services are often fragmented.[4] Mental illness in 
adolescents is associated with significant disease burden, such as poor 
academic achievement, suicide, violence, substance use, pregnancy and 
potentially increased risk of psychopathology later in adulthood.[4] The 
aetiology of mental illness in adolescents is multifactorial and includes 
biological factors, such as genetic vulnerability, in utero exposure to 
toxins, substance abuse and head trauma. Psychosocial factors include 
abuse, neglect, bereavement, family conflict, bullying and stressful life 
events.[4] Protective factors include familial ties and social support.[2]
While the Diagnostic and Statistical Manual of Mental Disorders, 
5th edition (DSM-5) diagnostic criteria are generally the same for 
adolescents and adults, the psychiatric assessment of the adolescent 
can be more challenging.[5] Adolescence is a period of significant 
emotional and behavioural change, which makes distinguishing 
normal development from psychiatric illness difficult. Most 
adolescents are not able to independently access health services, and 
are often accompanied by a caregiver. This may raise challenges, as 
adolescents may be reluctant to engage with the practitioner, may 
fear disclosure of personal information to the caregiver, or may fear 
stigmatisation by others. Practitioners should guard against any 
perception of collusion with the caregiver.
Adolescents may often present with vague, nonspecific symptoms, 
as they may be unable to express their emotional distress. Finally, 
there is often comorbidity between the psychiatric disorders, 
substance use and medical disorders, which may further contribute 
to the challenge.[4]
The substantial evidence of a high prevalence and burden of 
mental illness in adolescence suggests a need for greater awareness 
of psychiatric disorders. Primary healthcare practitioners should 
consider mental illness and suicide risk when assessing adolescents. 
A variety of screening tools are available to assist with assessment, 
including: the Paediatric Symptom Checklist, the Strengths and 
Difficulties Questionnaire (SDQ), and the Reporting Questionnaire 
for Children.[6-8] The SDQ has been used in the South African setting 
and is available in several languages.  
Although the evidence base for management of psychiatric 
disorders in adolescents is improving, there is still a dire need for 
further pharmacological and psychosocial intervention studies.[4] 
General treatment principles include establishing a therapeutic 
alliance, involvement of family and school, and use of a multimodal 
treatment plan that includes psycho-education and pharmacological 
and psychosocial interventions. There is increasing recognition of 
the efficacy of psychotropic medication in this age group. Medication 
use is determined by the type and severity of the psychiatric disorder, 
past psychiatric history, family history, medical history and patient 
and family preference.[9] When prescribing medication, one has 
to consider the appropriate dosage and slow titration, and avoid 
polypharmacy.  
Identifying common mental health 
problems 
The objective of this article is to highlight the high prevalence 
of psychiatric disorders in adolescents and to provide a case-
based clinical overview of common mental health disorders and 
interventions available for adolescents.  
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Case report
A 15-year-old girl presented after a panic attack. The patient and her 
parents reported that she suffered from irritable mood, withdrawal, 
tearful bouts, excessive worry, poor concentration at school (poor 
marks in last school report), loss of weight and disturbed sleep for 
4 months. There were no psychotic symptoms and she did not use 
substances. On further enquiry the patient revealed that she was 
almost raped while out with friends. Collateral information from the 
teacher revealed that the patient had always been anxious, especially 
during public speaking and interacting with others, and that there 
was deterioration in her academic work more recently.  
The assessment of this patient includes a comprehensive history 
from the patient and her family, collateral information from the 
school, a physical examination, a mental state examination and any 
relevant investigations to exclude a medical disorder. 
The diagnostic considerations of the abovementioned adolescent 
should include the disorders listed below. 
Mood disorders
Depression
The prevalence of depression ranges from 4% to 8% in adolescents.[10]
The DSM-5 diagnostic criteria for depression in adolescents and 
adults are the same.[5] Adolescents are more likely to present with 
irritable mood, apathy, sadness, low self-esteem, social withdrawal, 
insomnia and impaired concentration. They often describe them selves 
as useless or life as boring. The diagnosis of depression may be missed 
in older adolescents, as they may present with oppositional or antisocial 
behaviour, use of substances and problems at school. Fifty percent of 
adolescents with depression have two or more comorbid disorders, 
including disruptive behaviour disorders and anxiety disorders.[9] 
A suicide risk assessment must be part of every evaluation. 
Hospitalisation may be indicated if the patient is actively suicidal 
or has recent suicidal behaviour. The treatment of depression is 
multimodal, with a combination of psychotherapy and increasing 
evidence for the use of antidepressants in this age group.
Psychotherapeutic interventions include psycho-education of the 
patient and family, supportive therapy and cognitive behavioural 
therapy.[9] Treatment with antidepressants is indicated for moderate 
to severe depression, recurrent depression and poor response to psy-
chotherapy. Selective serotonin reuptake inhibitors (SSRIs) are con-
sidered as the first-line intervention for adolescents with depression. 
In this regard, the most evidence has currently been accumulated for 
the SSRI, fluoxetine.[11] Tricyclic antidepressants are not effective for 
paediatric depression. The risk of suicide with SSRI antidepressant 
initiation in children and adolescents is controversial.[11] The poten-
tial risk of treatment-emergent agitation and suicidal ideation associ-
ated with SSRI medication can be managed with close monitoring of 
the patient for self-harm and informed consent from the caregiver for 
the use of psychotropic medication. Treatment with antidepressants 
should be continued for 6 - 12 months after recovery and should be 
tapered off over 6 - 12 weeks at the end of treatment.[9]
Trauma- and stressor-related disorders 
Post-traumatic stress disorder 
There is a high prevalence of trauma in our society and approximately 
a quarter of all individuals who experience significant trauma may 
develop post-traumatic stress disorder (PTSD).[12] 
 Adolescents with PTSD develop symptoms in response to a 
traumatic event involving actual or threatened death, serious injury 
or sexual violence. The patient may have experienced the event 
personally or it may have occurred to another, with the patient 
witnessing or being informed of it. Patients with this disorder, 
experience intrusive symptoms such as recurrent recollections, 
dreams, flashbacks and persistent severe psychological and physio-
logical reactions to reminders of the event. They attempt to avoid 
thinking about the occurrence and external reminders of the trauma. 
Disturbances in mood and cognition occur, such as fear, guilt, 
detachment and memory impairment. Furthermore, there may be 
alterations in arousal and reactivity levels, such as hypervigilance and 
increased startle response.[5] 
Acute stress disorder 
Acute stress disorder (ASD) presents very similarly to PTSD. 
While the traumatic event criteria and symptoms are identical, it 
differs with regard to duration. ASD symptoms last for 3 days - 1 month, 
while PTSD symptoms are present for >1 month.[5] It is estimated that 
half of PTSD patients will first present with ASD. After exposure to a 
traumatic event, many adolescents experience a degree of distressing 
symptoms, but will not progress to developing a trauma-related 
disorder. For those manifesting only mild symptoms for <4 weeks, it 
may be appropriate to adopt a watchful waiting position.[12] 
The evidence base supports the use of trauma-focused psycho-
therapy, in particular cognitive behavioural therapy.[12] Medication 
may be warranted for severe and persisting symptoms, as well as for 
symptoms that fail to respond to psychotherapy. There is a marked 
paucity of pharmacological treatment studies in adolescents. Based 
on the available data, an SSRI is an appropriate choice, noting the 
abovementioned cautions. Psychotherapy and medication are often 
combined.[13] 
Adjustment disorder
Adolescents may also react to stressors of lesser severity than those 
associated with the conditions noted above. An adjustment disorder refers 
to the development of emotional or behavioural symptoms in response 
to and within 3 months of a stressor that does not meet the criteria for 
a traumatic event. The reaction is disproportionate to the severity of the 
stressor and is associated with functional impairment.[5] The disorder 
may present with varied symptoms, such as anxiety, depression 
and behavioural disturbances. Adjustment disorder in adolescents is 
associated with an increased risk of suicidal behaviour and, at a later 
stage, psychiatric disorders.[14]
Crisis intervention and brief psychotherapy may be useful options. 
Pharmacotherapy is generally not indicated, except for short-term 
relief of insomnia and anxiety symptoms.[14]
Anxiety disorders
Social anxiety disorder (social phobia)
Patients with this disorder experience marked fear or anxiety in 
response to social situations in which they are under the scrutiny 
of others. They fear that their behaviour will be embarrassing, 
humiliating or lead to rejection, or be perceived as offensive to others. 
The severity of symptoms is in excess of the actual risks posed by the 
situation. Patients avoid such situations or endure them with intense 
fear or anxiety.[5] While many people experience some degree of 
anxiety in social situations, it is generally only those with the disorder 
that experience resultant functional impairment. 
Generalised anxiety disorder 
The prevalence of generalised anxiety disorder (GAD) among 
children and adolescents has been estimated to be as high as 
10%.[15]
GAD is characterised by excessive anxiety and worry over a 
variety of day-to-day issues. The excessive anxiety occurs almost 
daily and persists for at least 6 months. The symptoms may include 
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restlessness, muscle tension, fatiguability, irritability, disturbed con-
centration and sleep,[5] and panic attacks. 
Panic attacks refer to brief periods of intense anxiety. During an 
attack a multitude of somatic symptoms may occur, such as tachy-
cardia, shortness of breath, nausea and paraesthesia. Psychological 
symptoms such as fear of dying or losing control, derealisation, 
and depersonalisation may also occur.[5] Panic attacks frequently 
occur in association with other psychiatric disorders. For example, a 
learner with social anxiety disorder may experience a panic attack if 
required to deliver a speech in front of an audience, or someone with 
PTSD may have an attack if reminded of their trauma. These panic 
attacks can be anticipated because they are triggered by identifiable 
situations.
Panic disorder 
Panic disorder comprises recurrent panic attacks that are unexpected, as 
they do not occur in response to an identifiable situation. Furthermore, 
the attacks induce a prolonged period (at least 1 month) of persistent 
worry or maladaptive behavioural change.[5] 
As somatic symptoms predominate, it is important to first exclude 
the possibility that the symptoms are the result of another medical 
condition or are substance related. 
Patients often display symptoms of more than one anxiety dis-
order.[5] The anxiety disorders share commonalities in aetiology 
and symptomatology; therefore, similar treatment approaches are 
used. The established treatments for anxiety disorders are psy-
chotherapy (with a good evidence base for cognitive behavioural 
therapy), medications (most evidence favouring the SSRIs), and 
combinations of these approaches.[13] There is only a small role 
for the use of benzo diazepines owing to side-effects and the risk 
of addiction.
While adolescents may also suffer from other anxiety disorders, 
such as separation anxiety disorder, specific phobias and agoraphobia, 
these are not common in this age group and therefore beyond the 
scope of this article. 
Conclusion
Psychiatric disorders in adolescents are common and often pose 
many clinical challenges with regard to assessment and treatment. 
Mental illness in adolescents is associated with significant short- and 
long-term morbidity. There is therefore an urgent need to increase 
awareness, and improve screening, detection and treatment of mental 
illness in this vulnerable group. An integrated healthcare system that 
provides medical and mental healthcare at primary and secondary level 
is critical to address the mental healthcare gap in adolescent services. 
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